5 active not recruiting. 5 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Active not recruiting 5 |
| Phase 2 | 2 | Active not recruiting 2 |
Follow Abdominal Neoplasms: new trials by email Literature Review of Abdominal Neoplasms trials Research Report on Abdominal Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Galunisertib Combined With Capecitabine in Advanced CRC With PM Galunisertib plus capecitabine - Colorectal Cancer Metastatic, Peritoneal Carcinomatosis | Phase 1 / Phase 2 | Active not recruiting | The Netherlands Cancer Institute | 31 | 2023-07-28 | 2026-07-13 |
| Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal Cancer PIPAC with Nal-IRI - Peritoneal Carcinomatosis, Peritoneal Metastases | Phase 1 | Active not recruiting | University Hospital, Ghent | 45 | 2022-11-21 | 2026-07-13 |
| Paclitaxel for the Treatment of Gastric or Gastroesophageal Cancer Paclitaxel - Clinical Stage IV Gastric Cancer AJCC v8, Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 | Phase 1 | Active not recruiting | M.D. Anderson Cancer Center | 27 | 2019-12-06 | 2026-10-06 |
| Feasibility and Safety of IMP321 (Eftilagimod Alpha) for Advanced Stage Solid Tumors IMP321, Avelumab - Solid Tumors, Peritoneal Carcinomatosis | Phase 1 | Active not recruiting | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 83 | 2017-08-15 | 2026-02-19 |
| PARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian Cancer Olaparib, Tremelimumab - Ovarian Cancer, Fallopian Tube Cancer | Phase 1 / Phase 2 | Active not recruiting | New Mexico Cancer Research Alliance | 50 | 2016-02-23 | 2025-05-23 |
Peritoneal Neoplasms (5) · Colorectal Neoplasms (2) · Appendiceal Neoplasms (1) · Bile Duct Neoplasms (1) · Carcinoma, Transitional Cell (1) · Cholangiocarcinoma (1) · Fallopian Tube Neoplasms (1) · Ovarian Neoplasms (1) · Pancreatic Neoplasms (1) · Stomach Neoplasms (1)
Digestive System Diseases (5) · Digestive System Neoplasms (5) · Neoplasms (5) · Neoplasms by Site (5) · Peritoneal Diseases (5) · Carcinoma (2) · Colonic Diseases (2) · Endocrine Gland Neoplasms (2) · Endocrine System Diseases (2) · Gastrointestinal Diseases (2) · Gastrointestinal Neoplasms (2) · Intestinal Diseases (2) · Intestinal Neoplasms (2) · Neoplasms by Histologic Type (2)
Capecitabine (1) · LY-2157299 (1) · Paclitaxel (1) · Taxes (1) · avelumab (1) · irinotecan sucrosofate (1) · olaparib (1) · soluble LAG-3 protein, human (1) · tremelimumab (1)
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest (1) · M.D. Anderson Cancer Center (1) · New Mexico Cancer Research Alliance (1) · The Netherlands Cancer Institute (1) · University Hospital, Ghent (1)
United States (2) · Belgium (1) · Germany (1) · Netherlands (1)
Brian D Badgwell (1) · Sarah F Adams, MD (1) · Wim P Ceelen, MD, PhD, Prof (1)